If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 130.00
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 15.00 (11.538%)
Open: 137.50
High: 137.50
Low: 137.50
Prev. Close: 137.50
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and business update

11 Apr 2022 07:00

RNS Number : 8730H
Manolete Partners PLC
11 April 2022
 

11 April 2022

 

Manolete Partners Plc

("Manolete" or the "Company")

 

Trading and business update: EBIT below expectations despite strong cash generation and completion of a large case post year end. Notification of results date.

Manolete Partners Plc (AIM: MANO), the leading listed insolvency litigation financing firm in the UK, is expected to report its audited full financial statements for the year ended 31 March 2022 on 24 June 2022.

Steven Cooklin, CEO of Manolete commented:

"As previously announced, our business has faced challenging trading conditions caused mainly by the UK Government's temporary restrictions on insolvencies. These measures were largely ended on 1 October 2021, however, the final elements stayed in place until 31 March 2022. The impact of the final elements of these measures has had a greater than expected effect as, allied to the Omicron related operational disruptions that impacted many professionals in our sector, the number of new case enquiries did not increase at the rate expected in the final quarter of our financial year. As a result, our EBIT for the year of £5-6m is below market expectations."

"However, Manolete has had a strong financial year in other respects. The impact of Omicron and the final elements of the temporary measures has impacted new case enquiries, causing unrealised revenue, and therefore group EBIT, to be lower than expected. However, the Company has been able to continue working well on its existing cases driving realised revenue and cashflow. The Company recorded record gross cash recoveries from completed cases[1] of £15.6m for FY22, which is 28% higher than FY21 and more than double the cash recovered on completed cases in FY20. After payments to IPs and legal costs, Manolete's retained share of this cash is up 45% to £9.7m (FY21: £6.7m)."

"While the EBIT for the FY22 financial year is below market expectations, the external factors driving this are now at an end, and there is expected to be an insolvency 'catch up' effect over the next 12 months and beyond which will provide Manolete with significantly increased opportunities to take on strong cases for the benefit of its shareholders and the business and creditor communities. New case enquiries have rebounded sharply upwards in the last 4 weeks as IPs and lawyers returned to more normal working conditions following the challenges of Omicron."

"The Company is in good shape going into the new financial year. Over the last few days in April, Manolete completed one of its larger case investments for £9.5m, with all cash firmly expected to be received within the next 25 days. Manolete's retained share of that will be c.£5.6m and will reduce net debt to just £6.5m, which is sharply lower than the £10.3m net debt reported at 30 September 2021."

 

Subject to the audit, which is due to commence soon, the Board expects to announce audited financial statements for the year ended 31 March 2022 on 24 June 2022 and will include:

· EBIT of c. £5-6m, this is below the market expectations due to the Government's widespread measures used to suppress the UK insolvency market and the more recent disruptive impact of the Omicron variant on the sector's professionals. The Government measures ended completely on the last day of the Company's financial year FY22.

· Record gross cash recoveries from completed cases of £15.6m for FY22 which is 28% higher than the £12.2m recorded for FY21 and 105% higher than the £7.6m recorded for FY20. The £15.6m was collected across 183 separate, completed UK insolvency claims, highlighting the granularity and breadth of the Company's business model.

· Manolete's retained share of the £15.6m cash after payments to IPs and legal costs is £9.7m which is 45% higher than the £6.7m comparative for FY21 - showing how the business is evolving to deliver excellent cash returns for our shareholders.

· FY23 cash recoveries have started very strongly as well, with the £9.5m large case settlement in the early days of April, all the cash from that case will be received later this month. Total gross cash recoveries for the month of April 2022 should be in excess of £10m for that month alone.

· 159 new insolvency litigation cases were financed in FY22 (20% lower than FY21 due to the exceptional UK Government restrictions on the insolvency market), with slightly more cases signed in the second half of the financial year, marking an end to the decline in the semi-annual number of new case investments that the Company had experienced as a result of those restrictions. The temporary emergency measures enacted by the UK Government in response to the COVID-19 pandemic commenced in June 2020 with the majority of those measures ended in October 2021 and then the remainder ending on 31 March 2022.

· 139 litigation cases were completed in FY22, which is higher than the 135 cases completed in FY21 and 157% more than the 54 cases completed in FY20. This is strong testament to the operational excellence of the Manolete team against the widespread disruptions caused by COVID-19.

· Shortly after the year end of 31 March 2022, Manolete completed one of its larger case investments for £9.5m. Manolete's retained share of this cash will be c.£5.6m and all of the cash is expected to be received within the next 25 days. Manolete recorded a Money Multiple of 1.9x on this case and the Company's cash profit on it is £2.7m compared to an unrealised profit estimate of £3.3m - this was a rare funded case giving Manolete less control over case costs. Over 90% of the Company's cases are purchased, giving Manolete full control of case costs.

· Following receipt of the c.£5.6m later this month, the Company's net debt will materially reduce to approximately £6.5m, leaving the large majority of the Company's £25m Revolving Credit Facility with HSBC unutilised.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

LEI: 213800R2X9V3KWCC4H47

 

For further information, please contact:

Manolete Partners Plc via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

Peel Hunt (NOMAD and Sole Broker) +44 (0)20 7418 8900

James Britton

Rishi Shah

Instinctif Partners (Financial PR)

Tim Linacre +44 (0)7949 939237

 

 

 

[1] Total cash received from completed cases (whether directly by the IP on Funded Cases or by the Company on Purchased Cases) - therefore before deductions for the legal costs incurred on the case and before payments to the relevant Insolvent Estate.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLVSTIAIIF
Date   Source Headline
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results
3rd Nov 20217:00 amRNSNotice of Half Year Results
6th Oct 20217:00 amRNSTrading Update
1st Oct 20212:52 pmRNSDirector/PDMR Dealings
22nd Sep 20219:57 amRNSResult of AGM
21st Sep 20217:00 amRNSAGM Statement
9th Jul 20214:30 pmRNSPosting of Annual Report and Notice of AGM
25th Jun 20217:00 amRNSManolete Partners ranked in Band 1 by Chambers
24th Jun 202112:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20217:00 amRNSFull Year Results
23rd Jun 20217:00 amRNSAppointment of Chairman Designate
14th Jun 202110:29 amRNSNotice of Full Year Results
1st Mar 202112:45 pmRNSTR-1: Notification of Major Holdings
23rd Feb 20217:00 amRNSUpdated Investor Presentation
22nd Feb 20217:00 amRNSInvestor Presentation
10th Feb 202111:28 amRNSTR-1: Notification of Major Holdings
10th Feb 20217:00 amRNSDirector/PDMR Dealings
9th Feb 20217:00 amRNSDirector/PDMR Dealings
1st Feb 20217:21 amRNSDirector/PDMR Dealings
29th Jan 20217:00 amRNSDirector/PDMR Dealings
28th Jan 20211:09 pmRNSTR-1: Notification of Major Holdings
28th Jan 202111:24 amRNSTR-1: Notification of Major Holdings
27th Jan 20212:42 pmRNSTR-1: Notification of Major Holdings
26th Jan 20214:40 pmRNSSecond Price Monitoring Extn
26th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20212:47 pmRNSQ3 Trading Update
5th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Dec 20202:02 pmRNSTR-1: Notification of Major Holdings
18th Nov 202010:29 amRNSLarge Case Update
12th Nov 20207:00 amRNSFurther Significant Case Completion
10th Nov 20207:00 amRNSHalf Year Results
3rd Nov 20202:52 pmRNSNotice of Half Year Results
1st Oct 20207:00 amRNSGrant of Share Options
22nd Sep 202011:51 amRNSResult of AGM
17th Sep 20207:00 amRNSDirector/PDMR Shareholding
15th Sep 20204:23 pmRNSTrading Update - Significant Case Completion
24th Jul 20205:20 pmRNSNotification of Major Holdings
15th Jul 20204:02 pmRNSNotification of Major Holdings
14th Jul 20207:00 amRNSResponse to Article Published by ShareProphets
13th Jul 20204:41 pmRNSSecond Price Monitoring Extn
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:46 pmRNSPosting of Annual Report and Notice of AGM
13th Jul 20209:05 amRNSSecond Price Monitoring Extn
13th Jul 20209:00 amRNSPrice Monitoring Extension
3rd Jul 20207:05 amRNSAppointment of Joint Broker
3rd Jul 20207:00 amRNSFull Year Results
30th Jun 20203:56 pmRNSNotice of Full Year Results
29th Jun 202011:08 amRNSUpdate on Judgment
22nd Jun 20207:00 amRNSChange of Date for Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.